Health Highlights: April 12, 2022

New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more
Philadelphia Becomes First US City to Bring Back Mask Mandate: Faced with rising COVID-19 case counts, the city announced Monday that it will reinstate an indoor mask mandate next week. Read more
Study Finds Just One Dose of HPV Vaccine May be Enough: A single shot provided as much protection against cervical cancer as the standard three-dose regimen, a finding that researchers say could be a game-changer in efforts to vaccinate more people against the human papillomavirus. Read more
Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk? Preliminary findings suggest a class of rheumatoid arthritis drugs known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. Read more
Related Posts
Climate Change Means U.S. A/C Demands Will Overwhelm Electrical Supply: Study
WEDNESDAY, Feb. 9, 2022 (HealthDay News) -- Global warming will lead to longer,...
Marriage Could Be a ‘Buffer’ Against Dementia
TUESDAY, Jan. 31, 2023 (HealthDay News) -- Tying the knot is now tied to...
COVID Vaccines Likely to Become Annual Shots: White House
WEDNESDAY, Sept. 7, 2022 (HealthDay News) -- COVID-19 vaccines will likely go...
Los anticuerpos contra las cepas tempranas de la COVID quizá no luchen contra las nuevas variantes: estudio
MIÉRCOLES, 22 de septiembre de 2021 (HealthDay News) -- Los anticuerpos de las...